J. Wang

发表

Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.

J Mallela, Z Shariat-Madar, D. Watson, 2011, Biochemical and biophysical research communications.

Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).

A. Mazar, J. Henkin, J. Wang, 1997, European journal of biochemistry.

Endothelin Stimulates Glucose Uptake and GLUT4 Translocation via Activation of Endothelin ETA Receptor in 3T3-L1 Adipocytes*

J. R. Wu-wong, W. Chiou, Jiahong Wang, 1999, The Journal of Biological Chemistry.

SV40 virus transformation down-regulates endothelin receptor.

J. R. Wu-wong, W. Chiou, J. Wang, 1999, Biochimica et biophysica acta.

Internalization of type-A endothelin receptor.

J. R. Wu-wong, W. Chiou, G. Gagné, 2000, Journal of cardiovascular pharmacology.

Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).

A. Schmaier, D. Watson, Z. Shariat-Madar, 2014, Current molecular medicine.

PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.

D. Kolte, Z. Shariat-Madar, J. Wang, 2012, Cardiovascular & hematological agents in medicinal chemistry.

Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.

A. Mazar, J. Henkin, D. Cines, 1996, Blood.

Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite.

Jean M. Severin, R A Smith, V. Giranda, 2000, Structure.

Biochemical characterization of a novel high‐affinity and specific plasma kallikrein inhibitor

D. Kolte, Z. Shariat-Madar, D. Holsworth, 2011, British journal of pharmacology.

Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution.

B. Lentz, V. Koppaka, M. Banerjee, 1996, Biochemistry.